AI-generated summary
The authors randomized 90 women with subclinical or latent human papillomavirus infection to low-dose interferon, high-dose interferon, or high-dose interferon plus red light therapy for four weeks. They report higher viral clearance and cure rates in the high-dose and combination groups, with the combination highest for vaginitis and cervicitis. Mild adverse effects were reported in 3 of 30 combination-group patients.
- Participants
- 90
- Who or what was studied
- Women diagnosed with subclinical or latent human papillomavirus infection
- Limits stated in the abstract
- The abstract does not describe the red light wavelength or dose, and it does not report the sample size per group or statistical details.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on journals.lww.com.
Record from PubMed, a service of the National Library of Medicine.
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Dose, Red light therapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.